Advanced search×

Structural and numerical abnormalities resolved in one-step analysis: the most common chromosomal rearrangements detected by comparative genomic hybridization in childhood acute lymphoblastic leukemia

Cancer Genet Cytogenet 200(2):6 (2010) PMID 20620600

Comparative genomic hybridization (CGH) is a technique that permits detection of chromosomal imbalances. This method allows the detection of gains and losses of genetic material at a resolution lower than 5 Mb. The limitations of conventional cytogenetic studies, such as morphologically insufficient quality of metaphases or the mitotic index, can be eliminated by use of CGH. It is particularly important in the diagnosis of leukemias, and CGH could be a useful tool enabling more precise cytogenetic analysis of leukemic cells. A group of 89 children with acute lymphoblastic leukemia was studied by means of CGH using bone marrow obtained from all consecutive pediatric patients. CGH experiments were performed according to the manufacturer's instruction with minor modifications. In addition, each sample was examined with standard GTG technique and fluorescence in situ hybridization. The conventional cytogenetics failed in 12 patients (13.5%), and 22 patients (24.7%) had a normal karyotype. Structural and numerical changes were found in 55 cases (61.8%) displaying a different abnormalities including deletions, trisomies, tetrasomies, isochromosomes, and markers with unknown origin. However, all samples were successfully analyzed by CGH. We have shown that high-resolution comparative genomic hybridization analysis is a reliable and relatively quick one-step method to identify main aberrations that would not be detected by either conventional G banding or by conventional fluorescence in situ hybridization. It should be considered to establish CGH as a routine analysis for screening patients with acute lymphoblastic leukemia.

DOI: 10.1016/j.cancergencyto.2010.04.016
Version: za2963e q8zae q8zbd q8zc8 q8zd3 q8ze7 q8zf7 q8zg6

Similar articles you may find interesting…

  1. Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with cy...

    Trials (2010) PMID 20137079

    This work demonstrates the importance of feasibility studies in preparation for multicentre clinical trials. It confirmed the uncertainty amongst clinicians and patients about the clinical question, enabled assessment of the number of potentially eligible patients, the proportion of patients and cli...
  2. POI03 Using natalizumab in highly active relapsing remitting multiple sclerosis in the UK.

    J Neurol Neurosurg Psychiatry 81(11):e53 (2010) PMID 20972134

    Introduction Natalizumab is licenced in the UK for highly active relapsing remitting multiple sclerosis (RRMS) which is in contrast to the original trials that only studied early RRMS. These original studies demonstrated a reduction in relapse rates of 82% after 1 year compared to th...
  3. Cryptosporidiosis associated with wildlife center, Scotland.

    pubmed 16(5):895-6 1 May 2010 PMID 20409402